Authors
Latest:
The complicated ins and outs of paediatric glaucomaEarly detection and diagnosis are key for these young patients
Latest:
Keratometry and total keratometry values are similar in healthy eyesAstigmatic values differed between K and TK readings
Latest:
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditionsClinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Latest:
New IOL offers patients greater spectacle independence over wider rangePatients desire spectacle independence at all distances. Early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.
Latest:
Personalising glaucoma surgery: The role of MIGSMinimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Latest:
A simple solution for complex corneasCorneal aberrations may occur more frequently than is generally appreciated, and they affect the visual outcomes following cataract surgery. Small-aperture optics provide a solution for a large category of patients who are otherwise not well served by complex IOLs.
Latest:
The ZEISS IOL Power Calculation Service. Providing guidance in complex casesAdvances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.
Latest:
Expert on floppy iris syndrome offers practical pearls for successStrategies for the management and prevention of floppy iris syndrome include intraoperative interventions and recommendations on alternatives to tamsulosin for medical therapy in men with cataracts.
Latest:
IRISS registry study offers real-world outcomesInvestigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.
Latest:
ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World LeadersOWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.
Latest:
Repeatable, high-quality imaging leads to better diabetic eye disease managementSD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed for accuracy results in optimisation of training for novice surgeons
Latest:
New wet AMD therapeutics seek to improve visual outcomes beyond the current standard of careBreakthrough technologies are raising the ceiling for functional visual outcomes
Latest:
Current approaches to treatment of uveitis with autoimmune diseaseUnderlying autoimmune disease alters uveitis therapy.
Latest:
Personalising glaucoma surgery: The role of MIGSMinimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
Brolucizumab for neovascular AMD: Safety guidance and clinician perspectivesAlthough the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits.
Latest:
Using swept-source OCT and OCT angiography to image choroidal tumoursSS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Latest:
AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGSInvestigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures
Latest:
To Infinity and (PRES)BYOND - The game changer for my practiceLourens van Zyl wanted to set himself apart in a highly competitive surrounding and saw a potential for practice building by offering solutions for presbyopia in patients without cataract. Within a few years this group became a significant segment of his practice in total share. ZEISS PRESBYOND was the game changer for a business success story.
Latest:
Stating the facts about combination myopia management treatmentsGrowing evidence supports dual therapy to slow progression.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
Simplifying glaucoma medical therapy for patients in the United StatesCompounded medications are playing a central role in the process.
Latest:
Extended depth-of-focus IOLs: A reviewA look at how EDOF technology can be categorised into five types
Latest:
Orbis brings school-based eye health intervention to children in IndiaThe nonprofit's Refractive Error Among Children programme allows for early detection, prevention and appropriate management of visual impairment.
Latest:
Impact of Durable Therapies on Patients and Clinics and Monitoring StrategiesPanelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Latest:
Half a century of developments in ophthalmology: One doctor’s reflectionsDr Goes reflects on a life at the forefront of ophthalmology, considering advancements in technology and the knowledge that has changed his practice and improved outcomes for patients.
Latest:
US FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasisOcuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents
